Laekna, Inc. engages in the clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company